Edition:
United States

LivaNova PLC (LIVN.OQ)

LIVN.OQ on NASDAQ Stock Exchange Global Select Market

88.54USD
20 Apr 2018
Change (% chg)

$0.41 (+0.47%)
Prev Close
$88.13
Open
$87.73
Day's High
$89.55
Day's Low
$87.73
Volume
93,748
Avg. Vol
146,573
52-wk High
$92.19
52-wk Low
$51.70

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  LIVN.OQ Industry Sector
P/E (TTM): -- 35.59 33.60
EPS (TTM): -- -- --
ROI: -- 14.13 13.19
ROE: -- 16.91 15.00

BRIEF-Livanova Bicarbon Aortic Valves Receive CE Mark

* LIVANOVA BICARBON AORTIC VALVES RECEIVE CE MARK FOR EXPANDED USE LABELING WITH LOWER-DOSE BLOOD THINNERS IN LOW-RISK PATIENTS Source text for Eikon: Further company coverage:

Mar 29 2018

BRIEF-Livanova Plc To Evaluate Treatment Outcomes For Novel Microburst Vns Therapy System

* LIVANOVA COMMENCES CLINICAL STUDY TO EVALUATE TREATMENT OUTCOMES FOR NOVEL MICROBURST VNS THERAPY SYSTEM Source text for Eikon: Further company coverage:

Mar 28 2018

BRIEF-Livanova Announces Enrollment For PERFECT Perceval Valve Clinical Trial In China

* LIVANOVA ANNOUNCES ENROLLMENT FOR PERFECT PERCEVAL VALVE CLINICAL TRIAL IN CHINA

Mar 22 2018

BRIEF-Microport Scientific Updates On Acquisition Of Business From Livanova PLC

* SELLER HAS AGREED TO SELL, CRM BUSINESS FOR AN INITIAL CONSIDERATION OF US$190 MILLION Source text for Eikon: Further company coverage:

Mar 08 2018

BRIEF-Livanova Enters Agreement To Divest Cardiac Rhythm Management Business To Microport Scientific Corp

* LIVANOVA ENTERS INTO DEFINITIVE AGREEMENT TO DIVEST ITS CARDIAC RHYTHM MANAGEMENT BUSINESS FRANCHISE TO MICROPORT SCIENTIFIC CORPORATION

Mar 08 2018

BRIEF-Livanova To Acquire Tandemlife

* LIVANOVA PLC - LIVANOVA HAS AGREED TO PAY UP TO $250 MILLION FOR TANDEMLIFE

Feb 14 2018

BRIEF-Livanova Initiates Believe Aortic Heart Valve Study In The U.S., Canada

* LIVANOVA INITIATES BELIEVE AORTIC HEART VALVE STUDY IN THE U.S. AND CANADA

Jan 11 2018

BRIEF-LivaNova Commences Global Restore-Life Study For Treatment-Resistant Depression

* LIVANOVA COMMENCES GLOBAL RESTORE-LIFE STUDY FOR TREATMENT-RESISTANT DEPRESSION Source text for Eikon: Further company coverage:

Jan 04 2018

BRIEF-Livanova To Acquire Imthera Medical

* LIVANOVA PLC SAYS ENTERED INTO AN AGREEMENT TO ACQUIRE REMAINING OUTSTANDING INTERESTS IN IMTHERA MEDICAL, INC.

Dec 05 2017

BRIEF-Microport Scientific's unit buys CRM business from Livanova

* ‍Unit buys CRM business for initial consideration of US$190 million​ from Livanova PLC Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Nov 20 2017

Earnings vs. Estimates

No consensus analysis data available.